Back to top
more

Nevro (NVRO)

(Delayed Data from NYSE)

$11.32 USD

11.32
284,846

-0.30 (-2.58%)

Updated Apr 26, 2024 04:00 PM ET

After-Market: $11.34 +0.02 (0.18%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value D Growth B Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 37% (94 out of 252)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Research for NVRO

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

Fiscal Year End for Nevro Corp falls in the month of December.

All items in Millions except Per Share data.

12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Assets          
Cash & Equivalents 323 374 362 588 238
Receivables 79 79 70 78 83
Notes Receivable 0 0 0 0 0
Inventories 119 100 94 83 92
Other Current Assets 10 10 5 4 10
Total Current Assets 531 563 531 753 422
Net Property & Equipment 25 22 21 14 12
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 0 0 0 0
Intangibles 66 0 0 0 0
Deposits & Other Assets 6 4 5 5 14
Total Assets 636 602 575 789 470
Liabilities & Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Notes Payable 0 0 0 0 0
Accounts Payable 23 27 32 23 16
Current Portion Long-Term Debt 0 0 0 169 0
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 45 47 46 43 51
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 16 5 5 4 4
Total Current Liabilities 83 79 82 239 71
Mortgages 0 0 0 0 0
Deferred Taxes/Income 0 0 0 0 0
Convertible Debt 0 0 0 0 0
Long-Term Debt 211 187 151 142 160
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 43 2 22 3 2
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 343 279 271 401 253
Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Preferred Stock 0 0 0 0 0
Common Stock (Par) 0 0 0 0 0
Capital Surplus 993 934 928 881 626
Retained Earnings -699 -607 -624 -493 -410
Other Equity 0 -3 0 1 0
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity 293 324 304 388 216
Total Liabilities & Shareholder's Equity 636 602 575 789 470
Total Common Equity 293 324 304 388 216
Shares Outstanding 36.20 35.40 34.90 34.40 31.00
Book Value Per Share 8.10 9.15 8.70 11.29 6.98

Fiscal Year End for Nevro Corp falls in the month of December.

All items in Millions except Per Share data.

3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Assets          
Cash & Equivalents -99,999 323 320 330 342
Receivables NA 79 69 69 66
Notes Receivable NA 0 0 0 0
Inventories NA 119 122 120 113
Other Current Assets NA 10 10 12 15
Total Current Assets NA 531 522 531 535
Net Property & Equipment NA 25 24 24 23
Investments & Advances NA 0 0 0 0
Other Non-Current Assets NA 0 0 0 0
Deferred Charges NA 0 0 0 0
Intangibles NA 66 0 0 0
Deposits & Other Assets NA 6 5 3 4
Total Assets NA 636 562 570 574
Liabilities & Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Notes Payable NA 0 0 0 0
Accounts Payable NA 23 29 30 29
Current Portion Long-Term Debt NA 0 0 0 0
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses NA 45 45 42 40
Income Taxes Payable NA 0 0 0 0
Other Current Liabilities NA 16 6 5 5
Total Current Liabilities NA 83 80 78 75
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 0 0 0 0
Convertible Debt NA 0 0 0 0
Long-Term Debt NA 211 188 187 187
Non-Current Capital Leases NA 0 0 0 0
Other Non-Current Liabilities NA 2 2 2
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities NA 343 276 275 273
Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 0 0 0 0
Capital Surplus NA 993 978 964 945
Retained Earnings NA -699 -690 -667 -642
Other Equity NA 0 -2 -2 -2
Treasury Stock NA 0 0 0 0
Total Shareholder's Equity NA 293 286 295 301
Total Liabilities & Shareholder's Equity NA 636 562 570 574
Total Common Equity 0 293 286 295 301
Shares Outstanding 36.40 36.20 36.20 36.10 35.80
Book Value Per Share 0.00 8.10 7.89 8.16 8.41